Data driven precision medicine: who is the driver?
Data driven precision medicine: who is the driver? |
|
https://doi.org/10.18632/oncotarget.27860
Sebastian Klein,
and Reinhard Büttner
|
| 253-254 |
Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells
Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells |
|
https://doi.org/10.18632/oncotarget.27878
Andrew Henry Lewis,
Cory Seth Bridges,
Viraaj Singh Punia,
Abraham Fausto Jornada Cooper,
Monica Puppi,
and H. Daniel Lacorazza
|
| 255-267 |
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors |
|
https://doi.org/10.18632/oncotarget.27887
Naoko Takebe,
Geraldine O'Sullivan Coyne,
Shivaani Kummar,
Jerry Collins,
Joel M. Reid,
Richard Piekarz,
Nancy Moore,
Lamin Juwara,
Barry C. Johnson,
Rachel Bishop,
Frank I. Lin,
Esther Mena,
Peter L. Choyke,
M. Liza Lindenberg,
Larry V. Rubinstein,
Cecilia Monge Bonilla,
Matthew P. Goetz,
Matthew M. Ames,
Renee M. McGovern,
Howard Streicher,
Joseph M. Covey,
James H. Doroshow,
and Alice P. Chen
|
| 268-277 |
Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer
Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27896
Jared A. Sninsky,
Kumar S. Bishnupuri,
Iván González,
Nikolaos A. Trikalinos,
Ling Chen,
and Brian K. Dieckgraefe
|
| 278-291 |
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model |
|
https://doi.org/10.18632/oncotarget.27886
Ali H. Zaidi,
Ronan J. Kelly,
Anastasia Gorbunova,
Ashten N. Omstead,
Madison S. Salvitti,
Ping Zheng,
Juliann E. Kosovec,
Soyoung Lee,
Shahin Ayazi,
Laila Babar,
Gene G. Finley,
Ajay Goel,
and Blair A. Jobe
|
| 292-303 |
Low concentrations of vorinostat decrease EB1 expression in GBM cells and affect microtubule dynamics, cell survival and migration
Low concentrations of vorinostat decrease EB1 expression in GBM cells and affect microtubule dynamics, cell survival and migration |
|
https://doi.org/10.18632/oncotarget.27892
Thomas Perez,
Raphaël Bergès,
Hélène Maccario,
Sarah Oddoux,
and Stéphane Honoré
|
| 304-315 |
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach |
|
https://doi.org/10.18632/oncotarget.27875
Enric Carcereny,
Alonso Fernández-Nistal,
Araceli López,
Carmen Montoto,
Andrea Naves,
Cristina Segú-Vergés,
Mireia Coma,
Guillem Jorba,
Baldomero Oliva,
and Jose Manuel Mas
|
| 316-332 |
The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma
The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.27881
Kazunori Tokuda,
Yuji Morine,
Katsuki Miyazaki,
Shinichiro Yamada,
Yu Saito,
Masaaki Nishi,
Takuya Tokunaga,
Tetsuya Ikemoto,
Satoru Imura,
and Mitsuo Shimada
|
| 333-343 |
Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer |
|
https://doi.org/10.18632/oncotarget.27873
Shuichi Matsumura,
Mikihito Nakamori,
Toshiaki Tsuji,
Tomoya Kato,
Masaki Nakamura,
Toshiyasu Ojima,
Hiroshi Fukuhara,
Yasushi Ino,
Tomoki Todo,
and Hiroki Yamaue
|
| 344-354 |
Quercetin shortened survival of radio-resistant B-1 cells in vitro and in vivo by restoring miR15a/16 expression
Quercetin shortened survival of radio-resistant B-1 cells in vitro and in vivo by restoring miR15a/16 expression |
|
https://doi.org/10.18632/oncotarget.27883
Yasmim Alefe Leuzzi Ramos,
Olivia Fonseca Souza,
Marilia Campos Tavares Novo,
Caroline Ferreira Cunha Guimarães,
and Ana Flavia Popi
|
| 355-365 |
Folic acid supplementation acts as a chemopreventive factor in tumorigenesis of hepatocellular carcinoma by inducing H3K9Me2-dependent transcriptional repression of LCN2
Folic acid supplementation acts as a chemopreventive factor in tumorigenesis of hepatocellular carcinoma by inducing H3K9Me2-dependent transcriptional repression of LCN2 |
|
https://doi.org/10.18632/oncotarget.27136
Yin-Ling Zhang,
Geng Xue,
Hui Miao,
Chuan-Chuan Zhou,
Shu-Han Sun,
and Yi Zhang
|
| 366-378 |
Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers
Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers |
|
https://doi.org/10.18632/oncotarget.27893
Nataliya Pidkovka,
Olena Rachkevych,
and Abbes Belkhiri
|
| 379-391 |
Correction: Comparison of the expression and function of Lin28A and Lin28B in colon cancer
Correction: Comparison of the expression and function of Lin28A and Lin28B in colon cancer |
|
https://doi.org/10.18632/oncotarget.27903
Tianzhen Wang,
Yan He,
Yuanyuan Zhu,
Mingwei Chen,
Mingjiao Weng,
Chao Yang,
Yan Zhang,
Ning Ning,
Ran Zhao,
Weiwei Yang,
Yinji Jin,
Jing Li,
Riju James Rajkumar Ezakiel Redpath,
Lei Zhang,
Xiaoming Jin,
Zhaohua Zhong,
Fengmin Zhang,
Yunwei Wei,
Guomin Shen,
Dong Wang,
Ying Liu,
Guangyu Wang,
and Xiaobo Li
|
| 392-393 |
